Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Bone Metastases × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Pain 3 Burns 2 Breakthrough Pain 2 Anemia, Sickle Cell 2 Agnosia 2 Pain, Postoperative 1 Pain, Intractable 1 Lung Neoplasms 1 Intrathecal Dexmedetomidine 1 Dyspnea, Paroxysmal 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Bone Metastases 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03071744 2019-12-09

Lazanda in Cancer Patients Receiving Palliative Radiation

University of California, San Diego

Phase 2 Terminated

6 enrolled 10 charts

Bone Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡